Furthermore, the spleen and liver of AML mice were significantly enlarged, and Runx3 knockdown significantly alleviated these symptoms (44.9% and 35.7% reduction of spleen weight and liver weight, respectively; Figure 2G). Here, RUNX3 is linked to acute myeloid leukemia.